406 related articles for article (PubMed ID: 25132313)
1. Novel endoscopic diagnosis for bladder cancer.
Lerner SP; Goh A
Cancer; 2015 Jan; 121(2):169-78. PubMed ID: 25132313
[TBL] [Abstract][Full Text] [Related]
2. Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - a prospective audit.
Ahmad S; Aboumarzouk O; Somani B; Nabi G; Kata SG
BJU Int; 2012 Dec; 110(11 Pt B):E596-600. PubMed ID: 22758907
[TBL] [Abstract][Full Text] [Related]
3. New imaging techniques for nonmuscle invasive bladder cancer.
von Rundstedt FC; Lerner SP
Curr Opin Urol; 2014 Sep; 24(5):532-9. PubMed ID: 25051025
[TBL] [Abstract][Full Text] [Related]
4. New optical imaging technologies for bladder cancer: considerations and perspectives.
Liu JJ; Droller MJ; Liao JC
J Urol; 2012 Aug; 188(2):361-8. PubMed ID: 22698620
[TBL] [Abstract][Full Text] [Related]
5. Early detection of carcinoma in situ of the bladder: a comparative study of white light cystoscopy, narrow band imaging, 5-ALA fluorescence cystoscopy and 3-dimensional optical coherence tomography.
Ren H; Park KC; Pan R; Waltzer WC; Shroyer KR; Pan Y
J Urol; 2012 Mar; 187(3):1063-70. PubMed ID: 22245332
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in optical imaging technologies for the detection of bladder cancer.
Raharja PAR; Hamid ARAH; Mochtar CA; Umbas R
Photodiagnosis Photodyn Ther; 2018 Dec; 24():192-197. PubMed ID: 30315954
[TBL] [Abstract][Full Text] [Related]
7. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.
Jocham D; Witjes F; Wagner S; Zeylemaker B; van Moorselaar J; Grimm MO; Muschter R; Popken G; König F; Knüchel R; Kurth KH
J Urol; 2005 Sep; 174(3):862-6; discussion 866. PubMed ID: 16093971
[TBL] [Abstract][Full Text] [Related]
8. High magnification cystoscopy in the primary diagnosis of bladder tumors.
Jichlinski P; Lovisa B
Curr Opin Urol; 2011 Sep; 21(5):398-402. PubMed ID: 21730856
[TBL] [Abstract][Full Text] [Related]
9. Advances in imaging technologies in the evaluation of high-grade bladder cancer.
Zlatev DV; Altobelli E; Liao JC
Urol Clin North Am; 2015 May; 42(2):147-57, vii. PubMed ID: 25882557
[TBL] [Abstract][Full Text] [Related]
10. Innovations in the endoscopic management of bladder cancer: is the era of white light cystoscopy over.
Soria F; Gurioli A; Peraldo F; Oderda M; Giona S; Ambrosini E; Frea B; Gontero P
Urologia; 2013 Jun; 80 Spec No 1():1-8. PubMed ID: 23813287
[TBL] [Abstract][Full Text] [Related]
11. Application of new technology in bladder cancer diagnosis and treatment.
Goh AC; Lerner SP
World J Urol; 2009 Jun; 27(3):301-7. PubMed ID: 19234856
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy.
Zaak D; Karl A; Knüchel R; Stepp H; Hartmann A; Reich O; Bachmann A; Siebels M; Popken G; Stief C
BJU Int; 2005 Aug; 96(2):217-22. PubMed ID: 16001963
[TBL] [Abstract][Full Text] [Related]
13. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.
Grossman HB; Gomella L; Fradet Y; Morales A; Presti J; Ritenour C; Nseyo U; Droller MJ;
J Urol; 2007 Jul; 178(1):62-7. PubMed ID: 17499283
[TBL] [Abstract][Full Text] [Related]
14. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.
Hungerhuber E; Stepp H; Kriegmair M; Stief C; Hofstetter A; Hartmann A; Knuechel R; Karl A; Tritschler S; Zaak D
Urology; 2007 Feb; 69(2):260-4. PubMed ID: 17320660
[TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer.
Goh AC; Tresser NJ; Shen SS; Lerner SP
Urology; 2008 Jul; 72(1):133-7. PubMed ID: 18598789
[TBL] [Abstract][Full Text] [Related]
16. Improved detection and reduced early recurrence of non-muscle-invasive bladder cancer using hexaminolaevulinate fluorescence cystoscopy: results of a multicentre prospective randomized study (PC B305).
Mostafid H; Bunce C;
BJU Int; 2009 Oct; 104(7):889-90. PubMed ID: 19549121
[No Abstract] [Full Text] [Related]
17. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy.
Schmidbauer J; Witjes F; Schmeller N; Donat R; Susani M; Marberger M;
J Urol; 2004 Jan; 171(1):135-8. PubMed ID: 14665861
[TBL] [Abstract][Full Text] [Related]
18. Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations.
Witjes JA; Babjuk M; Gontero P; Jacqmin D; Karl A; Kruck S; Mariappan P; Palou Redorta J; Stenzl A; van Velthoven R; Zaak D
Eur Urol; 2014 Nov; 66(5):863-71. PubMed ID: 25001887
[TBL] [Abstract][Full Text] [Related]
19. [Transurethral bladder resection of non muscle invasive bladder cancer with Hexvix ®].
Seisen T; Rouprêt M
Prog Urol; 2013 Nov; 23(14):1177-80. PubMed ID: 24176406
[TBL] [Abstract][Full Text] [Related]
20. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.
Fradet Y; Grossman HB; Gomella L; Lerner S; Cookson M; Albala D; Droller MJ;
J Urol; 2007 Jul; 178(1):68-73; discussion 73. PubMed ID: 17499291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
